In their study, the genes GCKR, KCNJ11, and TCF7 were associated with hypertriglyceridemia and diabetes, while the LPIN1 and SLC22A1 genes were linked to a favorable response to antidiabetic drugs like rosiglitazone and metformin [100]. The gene discussed is SLC22A1; the disease is hypertriglyceridemia.